Page last updated: 2024-08-24

gemcitabine and pd 184352

gemcitabine has been researched along with pd 184352 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1
Altiok, S; Amador, ML; Bouraoud, N; Cusatis, G; Danenberg, K; Danenberg, PV; Eshleman, J; Hidalgo, M; Hruban, RH; Iacobuzio-Donahue, C; Jimeno, A; Karikari, C; Kulesza, P; Kuramochi, H; Maitra, A; Messersmith, W; Rubio-Viqueira, B; Salimi-Moosavi, H; Shi, C; Singh, S; Tanaka, K; Yeo, C; Zhang, X1

Other Studies

2 other study(ies) available for gemcitabine and pd 184352

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013
An in vivo platform for translational drug development in pancreatic cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Aug-01, Volume: 12, Issue:15

    Topics: Animals; Antineoplastic Agents; Benzamides; Carcinoma; Deoxycytidine; Disease Models, Animal; Female; Gemcitabine; Humans; Injections, Intraperitoneal; Injections, Subcutaneous; Kinetics; Mice; Mice, Nude; Pancreatic Neoplasms; Predictive Value of Tests; Sirolimus; Transplantation, Heterologous; Xenograft Model Antitumor Assays

2006